Personal information

Other IDs

SciProfiles: 2498810

Activities

Collapse all

Employment (1)

Icahn School of Medicine at Mount Sinai: New York, US

2024-05 to present | Post Doctoral Fellow (Microbiology)
Employment
Source: Self-asserted source
Dilhan J. Perera

Education and qualifications (2)

McGill University: Montreal, CA

2017-09 to 2024-02 | Doctor of Philosophy (Experimental Medicine)
Education
Source: Self-asserted source
Dilhan J. Perera

McGill University: Montreal, CA

2013-09 to 2017-05 | Bachelor's of Science (Microbiology and Immunology)
Education
Source: Self-asserted source
Dilhan J. Perera

Professional activities (1)

American Association For Cancer Research: Philadelphia, US

2024-06 to present | Associate Member
Membership
Source: Self-asserted source
Dilhan J. Perera

Funding (2)

Intranasal Delivery of a S. mansoni Cathepsin B expressing Adenovirus Provides Sterilizing Immunity from Schistosomiasis

2021-05-01 to 2024-04-30 | Grant
Canadian Institutes of Health Research (Ottawa, CA)
URL: https://app.dimensions.ai/details/grant/grant.9879575
GRANT_NUMBER:

grant.9879575
Source: Self-asserted source
Dilhan J. Perera via DimensionsWizard

Développement d'un vaccin anti-schistosome par voie intranasale pour l'obtention d'une immunité stérilisante contre la schistosomiase.

2021-04-01 to 2025-03-31 | Grant
Fonds de Recherche du Québec - Santé (Montreal, CA)
URL: https://app.dimensions.ai/details/grant/grant.9719490
GRANT_NUMBER: 307544
Source: Self-asserted source
Dilhan J. Perera via DimensionsWizard

Works (12)

Beyond schistosomiasis: unraveling co-infections and altered immunity

Clinical Microbiology Reviews
2024-03-14 | Journal article
DOI: 10.1128/cmr.00098-23
Contributors: Dilhan J. Perera; Cal Koger-Pease; Kayla Paulini; Mohamed Daoudi; Momar Ndao; Louisa A. Messenger
Source: check_circle
Crossref

BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine

2023-03-22 | Preprint
DOI: 10.1101/2023.03.21.533720
Contributors: Dilhan J. Perera; Pilar Domenech; George Giorgi Babuadze; Maedeh Naghibosadat; Fernando Alvarez; Cal Koger-Pease; Lydia Labrie; Matthew Stuible; Yves Durocher; Ciriaco A. Piccirillo et al.
Source: check_circle
Crossref

Salmonella Typhimurium expressing chromosomally integrated Schistosoma mansoni Cathepsin B protects against schistosomiasis in mice

npj Vaccines
2023-02-27 | Journal article
DOI: 10.1038/s41541-023-00599-w
Contributors: Adam S. Hassan; Sébastien Houle; Lydia Labrie; Dilhan J. Perera; Charles M. Dozois; Brian J. Ward; Momar Ndao
Source: check_circle
Crossref

Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections

Pharmaceuticals
2023-02-22 | Journal article
DOI: 10.3390/ph16030334
Contributors: Cal Koger-Pease; Dilhan J. Perera; Momar Ndao
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Investigating the Leishmania donovani sacp Gene and Its Role in Macrophage Infection and Survival in Mice

Tropical Medicine and Infectious Disease
2022-11-18 | Journal article
DOI: 10.3390/tropicalmed7110384
Contributors: Kayla Paulini; Patrick Lypaczewski; Wen-Wei Zhang; Dilhan J. Perera; Momar Ndao; Greg Matlashewski
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Strongyloides: a Minireview and Update

Clinical Microbiology Newsletter
2022-09 | Journal article
DOI: 10.1016/j.clinmicnews.2022.09.001
Part of ISSN: 0196-4399
Contributors: Momar Ndao; Dilhan J. Perera; Kamran Kadkhoda
Source: Self-asserted source
Dilhan J. Perera

A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice

eBioMedicine
2022-06 | Journal article
DOI: 10.1016/j.ebiom.2022.104036
Part of ISSN: 2352-3964
Contributors: Dilhan J. Perera; Adam Hassan; Sunny S. Liu; Seyyed Mehdy Elahi; Christine Gadoury; Risini D. Weeratna; Rénald Gilbert; Momar Ndao
Source: Self-asserted source
Dilhan J. Perera

Therapeutic activity of a Salmonella-vectored Schistosoma mansoni vaccine in a mouse model of chronic infection

Vaccine
2021-09 | Journal article
DOI: 10.1016/j.vaccine.2021.08.031
Contributors: Adam S. Hassan; Dilhan J. Perera; Brian J. Ward; Momar Ndao
Source: check_circle
Crossref

Promising Technologies in the Field of Helminth Vaccines

Frontiers in Immunology
2021-08-19 | Journal article
DOI: 10.3389/fimmu.2021.711650
Part of ISSN: 1664-3224
Contributors: Dilhan J. Perera; Momar Ndao
Source: Self-asserted source
Dilhan J. Perera

Adjuvanted <i>Schistosoma mansoni</i>-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model.

Frontiers in immunology
2020-11-16 | Journal article
DOI: 10.3389/fimmu.2020.605288
PMID: 33304354
PMC: PMC7701121
Source: Self-asserted source
Dilhan J. Perera

A Procedure for Analyzing the Proteomic Profile of Schistosoma mansoni Cercariae.

Methods in molecular biology (Clifton, N.J.)
2020-01-01 | Journal article
DOI: 10.1007/978-1-0716-0635-3_7
PMID: 32451997
Contributors: Dilhan J. Perera
Source: Self-asserted source
Dilhan J. Perera

Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model.

PLoS neglected tropical diseases
2019-12-02 | Journal article
DOI: 10.1371/journal.pntd.0007490
PMID: 31790394
PMC: PMC6907844
Source: Self-asserted source
Dilhan J. Perera
How many people are using ORCID?